27 results on '"Massari, Francesco"'
Search Results
2. Risk of toxicity with immunotherapy–tyrosine kinase inhibitors for metastatic renal cell carcinoma: a meta-analysis of randomized controlled trials
3. Quality of life assessment in renal cell carcinoma Phase II and III clinical trials published between 2010 and 2020: a systematic review
4. A brand-new CAR for macrophages: is it time to fire up the engines of a new era for the treatment of renal cell carcinoma?
5. The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer
6. Oncology clinical trials in the time of COVID-19: how a pandemic can revolutionize patients’ care
7. Risk of toxicity with immunotherapy-tyrosine kinase inhibitors for metastatic renal cell carcinoma: a meta-analysis of randomized controlled trials.
8. Germline and somatic mutations in prostate cancer: focus on defective DNA repair, PARP inhibitors and immunotherapy
9. BAP1 in solid tumors
10. Hypothyroidism in patients with hepatocellular carcinoma receiving cabozantinib: an unassessed issue
11. Combination immunotherapy in metastatic renal cell carcinoma. Are we leaving something back?
12. Enzalutamide after chemotherapy in advanced castration-resistant prostate cancer: the Italian Named Patient Program
13. Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer
14. Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets
15. Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 1 – kidney cancer
16. Immunotargeting and personalized therapies in genitourinary cancers
17. Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: Part 2 – Prostate and Bladder Cancer
18. Prostate cancer glands with cribriform architecture and with glomeruloid features should be considered as Gleason pattern 4 and not pattern 3
19. 2015 And Human Cancer: Back to Overall Survival
20. Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer
21. Impact of visceral metastases on outcome to abiraterone after docetaxel in castration-resistant prostate cancer patients
22. Inside the 2015 ASCO Genitourinary Cancers Symposium
23. Suppression of mTOR pathway in solid tumors: lessons learned from clinical experience in renal cell carcinoma and neuroendocrine tumors and new perspectives
24. Present and future of personalized medicine in adult genitourinary tumors
25. Kidney cancer and 2014: is innovation really over?
26. Prognostic and predictive factors in patients treated with chemotherapy for advanced urothelial cancer: where do we stand?
27. Selected news from the 2014 Genitourinary Cancers Symposium: translating novel strategies into clinical practice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.